Saturday, February 4, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Clinical Trials
1 of 2
Previous |
Next
Clinical Trials
EDC brings clinical development into focus
Statistics is the ultimate in fuzzy mathematics. While statistics may not actually find the needle in the haystack, by using statistics at least we know the odds of locating the needle before it's time for dinner.
Comments
(2)
Rare dedication
Sigma-Tau Pharmaceuticals specializes in discovering novel therapies for patients suffering with rare diseases. After all, this unique company is keen to stress, ‘there’s no difference between a disease that affects 300 or 300 million people’.
No Comments
A successful program to engage the public
AWARE for all – clinical research education day
No Comments
Biomarkers: where are we and where are we going?
By J. Fred Pritchard, PhD, Malle Jurima-Romet, PhD, Lena King, PhD, DABT, and Claudio Carini, MD, PhD, FRCP(Path)
No Comments
1 of 2
Previous |
Next
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.